SynAct Pharma AB (STO: SYNACT)

SynAct Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4.99	22.03	32.04	28.84	55.98	33.73
Cash & Short-Term Investments	4.99	22.03	32.04	28.84	55.98	33.73
Cash Growth	-86.37%	-31.25%	11.11%	-48.49%	65.94%	-20.35%
Other Receivables	0.46	0.64	0.84	0.7	0.44	0.27
Receivables	0.46	0.64	0.84	0.7	0.44	0.27
Prepaid Expenses	3.36	2.64	0.47	0.5	0.07	0.11
Total Current Assets	8.81	25.3	33.34	30.04	56.49	34.11
Other Intangible Assets	1.63	1.63	1.63	1.63	1.63	1.63
Long-Term Deferred Charges	101.96	96.25	76.65	60.02	42.69	27.8
Other Long-Term Assets	0	-	-	-	-	-
Total Assets	112.4	123.19	111.62	91.69	100.82	63.53
Accounts Payable	2.25	2.49	3.17	0.79	1.91	0.43
Accrued Expenses	2.05	2.63	1.4	1.06	1.57	2.64
Other Current Liabilities	3.29	3.41	0.72	0.57	0.51	0.56
Total Current Liabilities	7.58	8.53	5.29	2.42	3.99	3.62
Long-Term Debt	0.8	0.8	0.8	0.8	0.8	0.8
Total Liabilities	8.38	9.33	6.09	3.22	4.79	4.42
Common Stock	11.71	11.71	8.53	4.15	4.15	2.01
Additional Paid-In Capital	166.26	166.26	144.65	118.87	118.87	77.6
Retained Earnings	-73.96	-64.12	-47.64	-34.55	-27	-20.5
Shareholders' Equity	104.02	113.86	105.53	88.47	96.02	59.11
Total Liabilities & Equity	112.4	123.19	111.62	91.69	100.82	63.53
Total Debt	0.8	0.8	0.8	0.8	0.8	0.8
Net Cash (Debt)	4.19	21.23	31.24	28.04	55.18	32.93
Net Cash Growth	-88.30%	-32.05%	11.42%	-49.19%	67.54%	-20.74%
Net Cash Per Share	0.09	0.53	1.29	1.78	3.48	4.31
Filing Date Shares Outstanding	44.53	44.53	32.42	15.78	15.78	7.63
Total Common Shares Outstanding	44.53	44.53	32.42	15.78	15.78	7.63
Working Capital	1.23	16.77	28.05	27.62	52.5	30.49
Book Value Per Share	2.34	2.56	3.26	5.61	6.09	7.74
Tangible Book Value	102.39	112.23	103.9	86.84	94.39	57.48
Tangible Book Value Per Share	2.30	2.52	3.20	5.50	5.98	7.53

Source: S&P Capital IQ. Standard template. Financial Sources.